Free Trial
NYSE:CC

Chemours (CC) Stock Price, News & Analysis

Chemours logo
$15.25 +0.06 (+0.42%)
Closing price 08/27/2025 03:59 PM Eastern
Extended Trading
$15.29 +0.04 (+0.24%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Chemours Stock (NYSE:CC)

Key Stats

Today's Range
$15.01
$15.35
50-Day Range
$10.61
$15.34
52-Week Range
$9.13
$22.38
Volume
1.79 million shs
Average Volume
4.52 million shs
Market Capitalization
$2.28 billion
P/E Ratio
N/A
Dividend Yield
2.29%
Price Target
$17.38
Consensus Rating
Moderate Buy

Company Overview

Chemours Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
73rd Percentile Overall Score

CC MarketRank™: 

Chemours scored higher than 73% of companies evaluated by MarketBeat, and ranked 65th out of 189 stocks in the basic materials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Chemours has received a consensus rating of Moderate Buy. The company's average rating score is 2.63, and is based on 5 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Chemours has only been the subject of 2 research reports in the past 90 days.

  • Read more about Chemours' stock forecast and price target.
  • Earnings Growth

    Earnings for Chemours are expected to grow by 33.50% in the coming year, from $2.03 to $2.71 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Chemours is -5.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Chemours is -5.45, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Chemours has a P/B Ratio of 9.53. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Chemours' valuation and earnings.
  • Percentage of Shares Shorted

    10.01% of the float of Chemours has been sold short.
  • Short Interest Ratio / Days to Cover

    Chemours has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Chemours has recently decreased by 7.06%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Chemours pays a meaningful dividend of 2.30%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Chemours does not have a long track record of dividend growth.

  • Dividend Sustainability

    Based on earnings estimates, Chemours will have a dividend payout ratio of 12.92% next year. This indicates that Chemours will be able to sustain or increase its dividend.

  • Read more about Chemours' dividend.
  • Percentage of Shares Shorted

    10.01% of the float of Chemours has been sold short.
  • Short Interest Ratio / Days to Cover

    Chemours has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Chemours has recently decreased by 7.06%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Chemours has a news sentiment score of 1.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.73 average news sentiment score of Basic Materials companies.
  • News Coverage This Week

    MarketBeat has tracked 14 news articles for Chemours this week, compared to 9 articles on an average week.
  • Search Interest

    Only 15 people have searched for CC on MarketBeat in the last 30 days. This is a decrease of -17% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Chemours to their MarketBeat watchlist in the last 30 days. This is a decrease of -88% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Chemours insiders have bought more of their company's stock than they have sold. Specifically, they have bought $250,437.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 0.47% of the stock of Chemours is held by insiders.

  • Percentage Held by Institutions

    76.26% of the stock of Chemours is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Chemours' insider trading history.
Receive CC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemours and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CC Stock News Headlines

The DuPont logo is seen on a sign at the entrance to the company's Spruance Plant on April 22, 2008…
New Jersey says 3 chemical makers agree to 'forever chemical' settlement worth up to $2 billion
DuPont and two other companies will pay New Jersey up to $2 billion to settle environmental claims stemming from PFAS, commonly referred to as “forever chemicals.”...
“Sell Nvidia before earnings”
Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has been chasing the AI giant, Eric says its biggest customers are now its biggest competitors — and that could spell trouble ahead. Instead, he’s urging investors to consider a little-known hardware company that’s already starting to take off. In fact, while Nvidia has slipped over the past 30 days, this “off-the-radar” stock is up 18% — and Eric believes the run is just beginning.tc pixel
Q3 Earnings Estimate for Chemours Issued By Zacks Research
FY2025 EPS Estimates for Chemours Lowered by Zacks Research
See More Headlines

CC Stock Analysis - Frequently Asked Questions

Chemours' stock was trading at $16.90 at the start of the year. Since then, CC stock has decreased by 9.7% and is now trading at $15.2540.

The Chemours Company (NYSE:CC) posted its quarterly earnings data on Tuesday, August, 5th. The specialty chemicals company reported $0.58 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.46 by $0.12. The business's revenue was up 5.0% compared to the same quarter last year.
Read the conference call transcript
.

Top institutional investors of Chemours include State Street Corp (4.08%), Ameriprise Financial Inc. (2.82%), Geode Capital Management LLC (2.33%) and JPMorgan Chase & Co. (2.26%). Insiders that own company stock include Mark Newman, Denise Dignam, Damian Gumpel, Shane Hostetter, Alisha Bellezza, Matthew S Abbott, Diane I Picho and Alvenia Scarborough.
View institutional ownership trends
.

Shares of CC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Chemours investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), AT&T (T), Tesla (TSLA), Chevron (CVX) and JPMorgan Chase & Co. (JPM).

Company Calendar

Ex-Dividend for 6/16 Dividend
5/16/2025
Record date for 6/16 Dividend
5/19/2025
Dividend Payable
6/16/2025
Last Earnings
8/05/2025
Record date for 9/12 Dividend
8/15/2025
Ex-Dividend for 9/12 Dividend
8/15/2025
Today
8/27/2025
Dividend Payable
9/12/2025
Next Earnings (Estimated)
11/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
CHEM - DIVERSIFD
Sub-Industry
Chemicals
Current Symbol
NYSE:CC
CIK
1627223
Fax
N/A
Employees
6,000
Year Founded
N/A

Price Target and Rating

High Price Target
$27.00
Low Price Target
$13.00
Potential Upside/Downside
+13.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.63
Research Coverage
8 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.80)
Trailing P/E Ratio
N/A
Forward P/E Ratio
7.51
P/E Growth
N/A
Net Income
$86 million
Net Margins
-7.19%
Pretax Margin
-4.67%
Return on Equity
35.14%
Return on Assets
2.45%

Debt

Debt-to-Equity Ratio
17.16
Current Ratio
1.68
Quick Ratio
0.83

Sales & Book Value

Annual Sales
$5.78 billion
Price / Sales
0.39
Cash Flow
$3.70 per share
Price / Cash Flow
4.12
Book Value
$1.60 per share
Price / Book
9.53

Miscellaneous

Outstanding Shares
149,700,000
Free Float
148,994,000
Market Cap
$2.28 billion
Optionable
Optionable
Beta
1.61

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NYSE:CC) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners